Authors:
Chisesi, T
Polistena, P
Contu, A
Coser, P
Indrizzi, L
Leoni, P
Majolino, I
Porcellini, A
Salvagno, L
Zambaldi, G
Rizzoli, V
Congiu, AM
Santini, G
Citation: T. Chisesi et al., Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-Hodgkin's lymphoma: An effective and non toxic therapeutic alternative for adult and elderly patients, LEUK LYMPH, 41(1-2), 2001, pp. 125-136
Authors:
Del Mastro, L
Venturini, M
Lionetto, R
Carnino, F
Guarneri, D
Gallo, L
Contu, A
Pronzato, P
Vesentini, L
Bergaglio, M
Comis, S
Rosso, R
Citation: L. Del Mastro et al., Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: Resultsof a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group, J CL ONCOL, 19(8), 2001, pp. 2213-2221
Authors:
Pezzella, G
Moslinger-Gehmayr, R
Contu, A
Citation: G. Pezzella et al., Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline, BREAST CANC, 70(1), 2001, pp. 1-10
Citation: A. Contu et H. Willmott, Comment on Wenger and Yanow. Knowing in practice: A 'delicate flower' in the organizational learning field, ORGANIZAT, 7(2), 2000, pp. 269-276
Authors:
Santini, G
Coser, P
Congiu, AM
Salvagno, L
De Souza, C
Sertoli, MR
Olivieri, A
Chisesi, T
Rubagotti, A
Truini, M
Contu, A
Porcellini, A
Zambaldi, G
Nati, S
Marino, G
Rizzoli, V
Citation: G. Santini et al., VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group, HAEMATOLOG, 85(2), 2000, pp. 160-166
Authors:
Sdrobolini, A
Contu, A
Massidda, B
Gasperoni, S
Recchia, F
Iannelli, A
Tomao, S
Romiti, A
Raffaele, M
Ortu, S
Campisi, C
Gebbia, V
Olmeo, N
Ionta, MT
Angiona, S
Di Costanzo, F
Citation: A. Sdrobolini et al., 5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: A phase II randomized trial, TUMORI, 86(3), 2000, pp. 211-214
Authors:
Di Costanzo, F
Canaletti, R
Sdrobolini, A
Olmeo, N
Luppi, G
Pucci, F
Cavicchi, F
Gasperoni, S
Rodino, C
Zironi, S
Angiona, S
Contu, A
Citation: F. Di Costanzo et al., Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer - A phase II study of the Italian Oncology Group for Clinical Research (GOIRC), AM J CL ONC, 23(3), 2000, pp. 314-318
Authors:
Roila, F
Ballatori, E
Ruggeri, B
De Angelis, V
Tonato, M
Bosnjak, S
Del Favero, A
Ciccarese, G
Basurto, C
Ciccarese, G
Palladino, MA
Porozzi, S
Marinkovic, Z
Neskovic-Konstantinovic, Z
Susnjar, S
Vasovic, S
Colakovic, S
Lukic, V
Radosavljevic, D
Fava, S
Grimi, E
Calcagno, A
De Paoli, A
Luoni, M
Tocci, A
Nuzzo, A
Laudadio, L
Di Blasio, A
Sacco, M
Contu, A
Olmeo, N
Pazzola, A
Baldino, G
Picece, V
Nicodemo, M
Cirillo, M
Recaldin, E
Dazzi, C
Cariello, A
Giovanis, P
Zumaglini, F
Rosati, G
Manzione, L
Bilancia, D
Rossi, A
Donati, D
Maccaferri, R
Malacarne, P
Labianca, R
Quadri, A
Pessi, MA
Cortesi, E
Martelli, O
Giuliodori, L
Silva, RR
Mari, D
Massidda, B
Ionta, MT
Alessandroni, P
Baldelli, A
Antimi, M
Minelli, M
Gridelli, C
Rossi, A
Passalacqua, R
Quarta, M
Sassi, M
Pinaglia, D
De Marino, E
Giampaolo, MA
Ciancola, F
Lalli, A
Di Felice, S
Casartelli, C
Citation: F. Roila et al., Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy, N ENG J MED, 342(21), 2000, pp. 1554-1559
Authors:
Frasci, G
Panza, N
Cornella, P
Nicolella, GP
Natale, M
Manzione, L
Bilancia, D
Cioffi, R
Maiorino, L
De Cataldis, G
Belli, M
Micillo, E
Mascia, V
Massidda, B
Lorusso, V
De Lena, M
Carpagnano, F
Contu, A
Pusceddu, G
Comella, G
Citation: G. Frasci et al., Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study, J CL ONCOL, 17(8), 1999, pp. 2316-2325